Other glucose metrics
3.9–10, −2.7
% Time in target 70–180 mg/dL (3.9–10 mmol/L) showed an absolute increase in the isCGM group (28.7% [16.6] at baseline to 36.4% [13.2]) at 12 weeks, and remained similar in the SMBG group (27.3% [16] and 25.1% [13]), however, this did not translate to a statistically significant difference between groups, +4.7% (CI: −2.7 to 13.4), Percentage of time spent in various glucose target ranges at baseline and at 12 weeks in the intervention and control groups. Red is percentage TBR or less than 70 mg/dL (<3.9 mmol/L), green is percentage TIR 70–180 mg/dL (3.9–10.0 mmol/L), and orange is percentage TAR over 180 mg/dL (>10.0 mmol/L). Values shown are mean percentage for the intervention and control groups. TAR, time above range; TBR, time below range; TIR, time in range.% Time spent <70 mg/dL (<3.9 mmol/L) showed a difference between groups favoring reduced time <70 mg/dL (<3.9 mmol/L) in the isCGM group (isCGM −6.4% and control +1.0% [CI: −10.6 to −4.2], % Time above 180 mg/dL (>10 mmol/mol) remained unchanged with no difference between groups at 12 weeks (−1.6% for isCGM and −3.8% for control group, respectively [CI: −6.6 to 11.1, There was no difference in mean glucose or glucose Coefficient of Variation percentage between groups at baseline or at 12 weeks.